RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD)
CUSIP: 75955J402
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock ($.001 par value)
- Shares outstanding
- 74,702,121
- Total 13F shares
- 13,555,167
- Share change
- -731,463
- Total reported value
- $40,671,232
- Put/Call ratio
- 50%
- Price per share
- $3.00
- Number of holders
- 78
- Value change
- -$3,047,999
- Number of buys
- 21
- Number of sells
- 48
Quarterly Holders Quick Answers
What is CUSIP 75955J402?
CUSIP 75955J402 identifies RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75955J402:
Top shareholders of RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
1.7%
|
1,256,705
|
$5,843,678 | — | 31 Mar 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
1.7%
|
1,240,034
|
$5,766,158 | — | 31 Mar 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.6%
|
1,200,000
|
$5,580,000 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.6%
|
1,181,186
|
$5,490,000 | — | 31 Mar 2024 | |
| PARSONS CAPITAL MANAGEMENT INC/RI |
13F
|
Company |
1.3%
|
973,520
|
$4,526,868 | — | 31 Mar 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
1%
|
759,000
|
$3,529,350 | — | 31 Mar 2024 | |
| Palo Alto Investors LP |
13F
|
Company |
0.98%
|
732,400
|
$3,405,660 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.84%
|
630,251
|
$2,930,667 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.77%
|
578,188
|
$2,688,574 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.46%
|
341,450
|
$1,587,742 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.44%
|
326,200
|
$1,516,830 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
256,087
|
$1,191,101 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.3%
|
227,039
|
$1,055,731 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.3%
|
224,846
|
$1,045,534 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.28%
|
210,576
|
$979,178 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.28%
|
207,870
|
$966,596 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
195,777
|
$910,363 | — | 31 Mar 2024 | |
| Guild Investment Management, Inc. |
13F
|
Company |
0.26%
|
191,000
|
$888,150 | — | 31 Mar 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.25%
|
184,338
|
$857,172 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.24%
|
175,978
|
$818,298 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.23%
|
175,229
|
$814,815 | — | 31 Mar 2024 | |
| RBF Capital, LLC |
13F
|
Company |
0.22%
|
165,474
|
$769,454 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.2%
|
145,999
|
$678,895 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.17%
|
129,285
|
$601,175 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.17%
|
125,916
|
$585,509 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.17%
|
123,813
|
$575,730 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.16%
|
120,514
|
$560,391 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.16%
|
118,243
|
$549,830 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
111,129
|
$516,750 | — | 31 Mar 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.14%
|
103,321
|
$480,000 | — | 31 Mar 2024 | |
| MGO ONE SEVEN LLC |
13F
|
Company |
0.13%
|
100,000
|
$465,000 | — | 31 Mar 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
99,379
|
$462,112 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.13%
|
96,010
|
$446,447 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.11%
|
83,847
|
$389,889 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
81,049
|
$376,877 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.11%
|
79,013
|
$367,410 | — | 31 Mar 2024 | |
| apricus wealth, LLC |
13F
|
Company |
0.11%
|
78,862
|
$366,708 | — | 31 Mar 2024 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
0.1%
|
73,500
|
$357,210 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.1%
|
73,820
|
$343,263 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.1%
|
72,979
|
$339,352 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
0.1%
|
72,318
|
$336,279 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.09%
|
70,544
|
$328,030 | — | 31 Mar 2024 | |
| AdvisorShares Investments LLC |
13F
|
Company |
0.09%
|
70,053
|
$325,746 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.07%
|
51,161
|
$237,899 | — | 31 Mar 2024 | |
| Point72 Asia (Singapore) Pte. Ltd. |
13F
|
Company |
0.07%
|
49,882
|
$231,951 | — | 31 Mar 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.06%
|
46,713
|
$217,000 | — | 31 Mar 2024 | |
| Jump Financial, LLC |
13F
|
Company |
0.06%
|
45,249
|
$210,408 | — | 31 Mar 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.05%
|
40,369
|
$187,717 | — | 31 Mar 2024 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.05%
|
36,320
|
$168,890 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.05%
|
35,008
|
$163,000 | — | 31 Mar 2024 |
Institutional Holders of RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) as of Q2 2024
As of 30 Jun 2024,
RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,555,167 shares.
The largest 10 holders included
VANGUARD GROUP INC, Deep Track Capital, LP, Vestal Point Capital, LP, ACADIAN ASSET MANAGEMENT LLC, FRANKLIN RESOURCES INC, PARSONS CAPITAL MANAGEMENT INC/RI, Palo Alto Investors LP, Opaleye Management Inc., BlackRock Inc., and JPMORGAN CHASE & CO.
This page lists
78
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
90
Q2 2024 holders
78
Holder diff
-12
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.